SCHEMBL6936922

SCHEMBL6936922

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.51
▸ RAPGEF3 O95398 2/20 0.45
▸ RXFP1 Q9HBX9 2/20 0.45
▸ DNMT1 P26358 1/20 0.44
▸ STING1 Q86WV6 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ GMNN O75496 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RAPGEF4 Q8WZA2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ NT5E P21589 1/20 0.42
▸ LARS1 Q9P2J5 1/20 0.42
▸ SARS1 P49591 1/20 0.42
▸ IARS1 P41252 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5963100 0.91 STING1 (0.47) ADORA3RAPGEF3RXFP1STING1LMNA
SCHEMBL8594450 0.90 AHCY (0.50) ADORA3DNMT1STING1LMNANT5E
SCHEMBL22216550 0.90 ADORA3 (0.54) ADORA3RXFP1DNMT1LMNANT5E
SCHEMBL4757808 0.90 ADORA3 (0.54) ADORA3RXFP1DNMT1LMNANT5E
SCHEMBL19961896 0.90 ADORA3 (0.54) ADORA3RXFP1DNMT1LMNANT5E
SCHEMBL22983991 0.86 STING1 (0.56) ADORA3RAPGEF3RXFP1STING1LMNA
SCHEMBL6895355 0.86 STING1 (0.56) ADORA3RAPGEF3RXFP1STING1LMNA
SCHEMBL16271105 0.86 STING1 (0.56) ADORA3RAPGEF3RXFP1STING1LMNA
SCHEMBL23813544 0.86 STING1 (0.56) ADORA3RAPGEF3RXFP1STING1LMNA
SCHEMBL9964279 0.86 STING1 (0.56) ADORA3RAPGEF3RXFP1STING1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0967220-B1 Novel arabinosyladenine derivatives NIPPON ZOKI PHARMACEUTICAL CO (JP) 2003-04-09 — — EP disclosed
US-6242429-B1 ANTIVIRAL ARA-A DERIVATIVES HAVING RESISTANCE TO METABOLISM BY ADENOSINEDEAMINASE NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2001-06-05 — — US disclosed
EP-0967220-A1 Novel arabinosyladenine derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1999-12-29 — — EP disclosed
Send feedback